HUGE: Moderna $MRNA share price skyrocketed 118.5% today after its cancer vaccine developed with Merck delivered successful results, validating years of research into mRNA-based cancer treatments.

The breakthrough could open the $240 billion-plus cancer-drug market to Moderna…